GHB-O-β-glucuronide in blood and urine is not a suitable tool for the extension of the detection window after GHB intake

Cash CD (1994) Gammahydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 18:291–304. doi: 10.1016/0149-7634(94)90031-0

Busardò FP, Jones AW (2015) GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol 13:47–70. doi: 10.2174/1570159X13666141210215423

Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C (1998) 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 29:14–22. doi: 10.1055/s-2007-973527

Dauvilliers Y, Arnulf I, Mignot E (2007) Narcolepsy with cataplexy. Lancet 369:499–511. doi: 10.1016/S0140-6736(07)60237-2

Mamelak M, Scharf MB, Woods M (1986) Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9:285–289 (PMID: 3704454)

Jazz Pharmaceuticals (2015) Highlights of prescribing information. https://www.xyremrems.com/documents/XYREM_Prescribing_Information.pdf . Accessed 13 Dec 2016

Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y (1977) Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 44:1014–1017

Kam PCA, Yoong FFY (1998) Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia 53:1195–1198. doi: 10.1046/j.1365-2044.1998.00603.x

Stell JM, Ryan JM (1996) Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness. BMJ 313(7054):424

Laborit H (1964) Sodium 4-hydroxybutyrate. Int J Neuropharmacol 3:433–451. doi: 10.1016/0028-3908(64)90074-7

Madea B, Musshoff F (2009) Knock-out drugs: their prevalence, modes of action, and means of detection. Dtsch Arztebl Int 106:341–347. doi: 10.3238/arztebl.2009.0341

Brenneisen R, Elsohly MA, Murphy TP, Passarelli J, Russmann S, Salamone SJ, Watson DE (2004) Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol 28:625–630. doi: 10.1093/jat/28.8.625

Bay T, Eghorn LF, Klein AB, Wellendorph P (2014) GHB receptor targets in the CNS: focus on high-affinity binding sites. Biochem Pharmacol 87:220–228. doi: 10.1016/j.bcp.2013.10.028

Abanades S, Farré M, Segura M, Pichini S, Pastor A, Pacifici R, Pellegrini M, de la Torre R (2007) Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring. Ther Drug Monit 29:64–70. doi: 10.1097/FTD.0b013e3180307e5e

LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA (2002) Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate. J Anal Toxicol 26:340–346. doi: 10.1093/jat/26.6.340

Andresen H, Sprys N, Schmoldt A, Mueller A, Iwersen-Bergmann S (2010) Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations. Forensic Sci Int 200:93–99. doi: 10.1016/j.forsciint.2010.03.035

Elliott SR (2004) Further evidence for the presence of GHB in postmortem biological fluid : implications for the interpretation of findings. J Anal Toxicol 28:20–26. doi: 10.1093/jat/28.1.20

Erdmann F, Zandt D, Auch J, Schütz H, Weiler G, Verhoff MA (2006) Investigations concerning the threshold value between endogenous and exogenous GHB (liquid ecstasy) (in German with English abstract). Arch Kriminol 217:129–136 (PMID: 16910296)

Abanades S, Farré M, Segura M, Pichini S, Barral D, Pacifici R, Pellegrini M, Fonseca F, Langohr K, De La Torre R (2006) Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann N Y Acad Sci 1074:559–576. doi: 10.1196/annals.1369.065

Haller C, Thai D, Jacob III  P, Dyer JE (2006) GHB urine concentrations after single-dose administration in humans. J Anal Toxicol 30:360–364. doi: 10.1093/jat/30.6.360

Petersen IN, Tortzen C, Kristensen JL, Pedersen DS, Breindahl T (2013) Identification of a new metabolite of GHB: gamma-hydroxybutyric acid glucuronide. J Anal Toxicol 37:291–297. doi: 10.1093/jat/bkt027

Wang X, Linnet K, Johansen SS (2016) Development of a UPLC–MS/MS method for determining γ-hydroxybutyric acid (GHB) and GHB glucuronide concentrations in hair and application to forensic cases. Forensic Toxicol 34:51–60. doi: 10.1007/s11419-015-0285-6

Mehling L-M, Piper T, Dib J, Pedersen DS, Madea B, Hess C, Thevis M (2016) Development and validation of a HPLC–QTOF-MS method for the determination of GHB-β-O-glucuronide and GHB-4-sulfate in plasma and urine. Forensic Toxicol. doi: 10.1007/s11419-016-0339-4

Petersen IN, Kristensen JL, Tortzen C, Breindahl T, Pedersen DS (2013) Synthesis and stability study of a new major metabolite of γ-hydroxybutyric acid. Beilstein J Org Chem 9:641–646. doi: 10.3762/bjoc.9.72

Lott S, Musshoff F, Madea B (2012) Estimation of gamma-hydroxybutyrate (GHB) co-consumption in serum samples of drivers positive for amphetamine or ecstasy. Forensic Sci Int 221:98–101. doi: 10.1016/j.forsciint.2012.04.009

Borgen LA, Okerholm RA, Lai A, Scharf MB (2004) The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 44:253–257. doi: 10.1177/0091270003262795

Mamelak M, Escriu JM, Stokan O (1977) The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry 12:273–288

Broughton R, Mamelak M (1980) Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy–cataplexy. Can J Neurol Sci 7:23–31. doi: 10.1017/S0317167100023659

King C, Rios G, Green M, Tephly T (2000) UDP-glucuronosyltransferases. Curr Drug Metab 1:143–161. doi: 10.2174/1389200003339171

Foti RS, Fisher MB (2005) Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int 153:109–116. doi: 10.1016/j.forsciint.2004.12.003

Crunelle CL, Neels H, Maudens K, De Doncker M, Cappelle D, Matthys F, Dom G, Fransen E, Michielsen P, De Keukeleire S, Covaci A, Yegles M (2016) Influence of body mass index on hair ethyl glucuronide concentrations. Alcohol Alcohol. doi: 10.1093/alcalc/agw079